Cystic Fibrosis
New England Journal of Medicine · 02.11.2023 · 389 (18) · 1693-1707
DOI: 10.1056/nejmra2216474 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 02.11.2023. Verfasst von Hartmut Grasemann und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Respiratory Medicine, Department of Pediatrics, and Translational Medicine, Research Institute, Hospital for Sick Children, Univ…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit wurde bisher 357-mal zitiert (Crossref) und nennt 100 Literaturangaben.
Abstract (Originalsprache)
This article reviews the pathophysiology, evaluation, and treatment of cystic fibrosis, including recent advances with the use of highly effective modulator therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Division of Respiratory Medicine, Department of Pediatrics, and Translational Medicine, Research Institute, Hospital for Sick Children, University of Toronto, Toronto.
ORCID-Profile: Felix Ratjen
Zitieren
APA
Grasemann, H., & Ratjen, F. (2023). Cystic Fibrosis. New England Journal of Medicine, 389(18), 1693-1707. https://doi.org/10.1056/nejmra2216474
Vancouver
Grasemann H, Ratjen F. Cystic Fibrosis. New England Journal of Medicine. 2023;389(18):1693-1707. doi:10.1056/nejmra2216474
BibTeX
@article{Grasemann2023,
author = {Grasemann, Hartmut and Ratjen, Felix},
title = {Cystic Fibrosis},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {18},
pages = {1693--1707},
doi = {10.1056/nejmra2216474}
}
EUVIMED